¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Maximum Strength Tylenol Allergy Sinus Day Time Caplets"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • drug allergy
    ¾à¹°¾Ë·¹¸£±â
  • delayed allergy
    Áö¿¬¾Ë·¹¸£±â
  • food allergy
    À½½Ä¾Ë·¹¸£±â
  • gastrointestinal allergy
    À§Àå¾Ë·¹¸£±â
  • immediate allergy
    Áï½Ã¾Ë·¹¸£±â
  • milk allergy
    ¿ìÀ¯¾Ë·¹¸£±â
  • nasal allergy
    Äھ˷¹¸£±â, ºñ¾Ë·¹¸£±â
  • penicillin allergy
    Æä´Ï½Ç¸°¾Ë·¹¸£±â
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕ°­µµ
  • dynamic strength
    1. µ¿Àû±Ù·Â 2. µ¿Àû°­µµ
  • ego strength
    ÀÚ¾ÆÈû
  • ionic strength
    À̿°­µµ
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maxillary sinus
    À§Åα¼, »ó¾Çµ¿
  • paranasal sinus
    ÄÚ°ç±¼, ºÎºñµ¿
  • endodermal sinus tumor
    ³»¹è¿±±¼Á¾¾ç
  • sinus tachycardia
    ±¼ºü¸¥¸Æ, µ¿¼ººó¸Æ
  • time
    ½Ã°£
  • acquisition time
    ȹµæ½Ã°£
  • activated partial thromboplastin time
    Ȱ¼ºÈ­ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • bleeding time
    ÃâÇ÷½Ã°£
  • clot retraction time
    ÇǶ±µÞ´ç±è½Ã°£, Ç÷º´ÅðÃà½Ã°£
  • coagulation time
    ÀÀ°í½Ã°£
  • colonic transit time
    ´ëÀåÅë°ú½Ã°£
  • diastolic filling time
    È®Àå±âÃæ¸¸½Ã°£
  • diffusion time
    È®»ê½Ã°£
  • expiratory pause time
    ³¯¼ûÈĽ¬´Â½Ã°£, È£±âÈÄÈÞÁö½Ã°£
  • expiratory phase time
    ³¯¼û½Ã°£, È£±â½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • day blindness
    ÁÖ°£¸Í, ÁÖ°£½Ã°¢»ó½Ç
  • day care
    ÁÖ°£µ¹º½
  • day-night cycle
    ³·¹ãÁÖ±â
  • infant day care
    ¿µ¾ÆÁÖ°£°¡·á
  • day
    ÀÏ
  • day hospital
    ³·º´¿ø
  • day residue
    ÁÖ°£ÀÜÀç
  • day surgery
    ¿Ü·¡¼ö¼ú, Åë¿ø¼ö¼ú
  • mean solar day
    Æò±ÕžçÀÏ
  • egg per day per female
    ¾ÏÄÆÇÏ·ç»ê¶õ¼ö
  • egg per day per worm
    ÃæÃ¼ÇÏ·ç»ê¶õ¼ö
  • five day fever
    ¿ÀÀÏ¿­, ÂüÈ£¿­
  • back strength
    µîÈû
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕÈû
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • abdominal allergy =gastrointestinal a.
    ¼ÒÈ­¼º(á¼ûùàõ) ¾Ë·¹¸£±â.
  • adhesive plaster allergy
    ¹Ýâ°í ¾Ë·¹¸£±â.
  • alimentary allergy
    ½Ä»ç¼º ¾Ë·¹¸£±â.
  • allergy
    ¾Ë·¹¸£±â, °ú¹Î¹ÝÀÀ
  • allergy
    ¾Ë·¯Áö
  • allergy
    ¾Ë·¹¸£±â.
  • allergy test
    ¾Ë·¹¸£±â½ÃÇè.
  • allergy, atopy
    ¾Ë·¹¸£±â, ¾ÆÅäÇÇ
  • allergy, contact
    Á¢Ã˼º ¾Ë·¹¸£±â
  • allergy, drug
    ¾à¹°¾Ë·¹¸£±â
  • allergy, food
    ½Äǰ¾Ë·¹¸£±â
  • allergy, fungal
    °õÆÎÀÌ ¾Ë·¹¸£±â
  • allergy, house dust
    Áý¸ÕÁö ¾Ë·¹¸£±â
  • allergy, pollen
    È­ºÐ ¾Ë·¹¸£±â, ²É°¡·ç ¾Ë·¹¸£±â
  • allergy, psychogenic
    ½ÉÀμº ¾Ë·¹¸£±â, Á¤½Å¼º ¾Ë·¹¸£±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • five day fever
    ¿ÀÀÏ¿­ ÂüÈ£¿­(óÒû½æð) .
  • infant day care
    ¿µ¾Æ ÁÖ°£ °¡·á
  • long day plants
    ÀåÀϽŰ(íþìíãÕÚª).
  • lunar day
    ÅÂÀ½ÀÏ(̬ËôËö).
  • mean solar day
    Æò±ÕžçÀÏ(̰˻̬ËâËö).
  • milk day
    ¿ìÀ¯ÀÏ(¡­ìí).
  • multiple fraction per day, MFD
    ÀÏÀÏ´ÙºÐÇÒÁ¶»ç¹ý
  • riley day syndrome
    ¸±¸®-µ¥ÀÌÁõÈıº(¡­ñøý¦ÏØ)
  • waking dream =day d.
    ¹éÀϸù(ÛÜìíÙÓ).
  • within day variation
    Àϳ»(ìíÒ®)º¯µ¿
  • corrected sinus node recovery time
    ±³Á¤ µ¿°áÀý ȸº¹½Ã°£.
  • sinus node recovery time
    µ¿°áÀýȸº¹½Ã°£.
  • cervical sinus branchial sinus
    ¸ñµ¿±¼
  • back strength
    ¹è±Ù·Â.
  • bending strength
    ±¼°î °­µµ(ÏÝÍØË­Óø).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Sinus [Caverna]
    µ¿±¼
    [¿¾ ¿ë¾î] µ¿
  • Occipital sinus
    µÚÅë¼öÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÈĵÎÁ¤¸Æµ¿
  • Groove for occipital sinus
    µÚÅë¼öÁ¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] Èĵε¿±¸
  • Lymphatic sinus
    ¸²ÇÁµ¿±¼
    [¿¾ ¿ë¾î] Àӯĵ¿
  • Marginal sinus
    ¸ð¼­¸®Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ¿¬Á¤¸Æµ¿
  • Cervical sinus
    ¸ñµ¿±¼
    [¿¾ ¿ë¾î] °æµ¿
  • Carotid sinus
    ¸ñµ¿¸ÆÆØ´ë
    [¿¾ ¿ë¾î] °æµ¿¸Æµ¿
  • Branch to carotid sinus
    ¸ñµ¿¸ÆÆØ´ë°¡Áö
    [¿¾ ¿ë¾î] °æµ¿¸Æµ¿Áö
  • Tarsal sinus
    ¹ß¸ñ»À±¼
    [¿¾ ¿ë¾î] Á·±Ùµ¿
  • Ethmoidal sinus
    ¹úÁý»Àµ¿±¼
    [¿¾ ¿ë¾î] »ç°ñµ¿
  • Urogenital sinus
    ºñ´¢»ý½Äµ¿±¼
    [¿¾ ¿ë¾î] ¿ä»ý½Äµ¿±¼
  • Cortical sinus
    ¼ÒÀýÁÖÀ§µ¿±¼
    [¿¾ ¿ë¾î] ÇÇÁúµ¿
  • Medullary sinus
    ¼ÓÁúµ¿±¼
    [¿¾ ¿ë¾î] ¼öÁúµ¿
  • Transverse sinus
    ½ÉÀ帷°¡·Îµ¿±¼
    [¿¾ ¿ë¾î] ½É¸·È¾µ¿
  • Coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • double beam in time spectrophotometer
    ½Ö±¤¼Ó ½Ã°£ ºÐ±¤±¤µµ°è(äªÎÃãÁÊàáÜÝÂÎÃÎÃÓøÍª)
  • elution time
    ¿ë¸® ½Ã°£ (éÁ×îãÁÊà)
  • fixed time assay
    ÀÏÁ¤½Ã°£(ìéïÒãÁÊà) ¾Æ½êÀÌ
  • generation time
    ¼¼´ë ½Ã°£(á¦ÓÛãÁÊà)
  • generation-time hypothesis
    ¼¼´ë ½Ã°£ ¼³(á¦ÓÛãÁÊààã)
  • half-reaction time
    ¹Ý¹ÝÀÀ ½Ã°£(ÚâÚãëëãÁÊà)
  • half-time
    ¹Ý ½Ã°£(ÚâãÁÊà)
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • mean generation time
    Æò±Õ¼¼´ë±â°£(øÁгá¦ÓáÑ¢Êà)
  • recovery time
    ȸ¼ö ½Ã°£(üÞâ¥ãÁÊà)
  • relaxation time
    ÀÌ¿Ï ½Ã°£(ì¬èÐãÁÊà)
  • residence time
    µ¿°Å ½Ã°£(ÔÒËÜãÁÊà)
  • resolving time
    "ºÐ¸®½Ã°£, ÇØ»ó½Ã°£"
  • retention time
    ¸Ó¹«¸§ ½Ã°£
  • rotational relaxation time
    ȸÀü À̿Ͻð£(üÞï®ì¬èÐãÁÊà)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • paranasal sinus [=PNS]
    ºÎºñµ¿
  • petrosal sinus
    ÃßüÁ¤¸Æµ¿
  • PNS [=paranasal sinus]
    ºÎºñµ¿
  • primitive urogenital sinus
    ¿ø½Ãºñ´¢»ý½Äµ¿, ¿ø½Ã´¢»ý½Äµ¿
  • pyriform sinus
    ¾ç¹è²Ãµ¿
  • sigmoid sinus
    ¿¡½ºÀÚÁ¤¸Æµ¿, S»óÁ¤¸Æµ¿
  • sinus
    µ¿
  • sinus arrhythmia
    µ¿ºÎÁ¤¸Æ, µ¿¼ººÎÁ¤¸Æ
  • sinus of Morganii
    ÈĵνÇ
  • sinus pericarinii
    µÎ°³º¯¿¬Á¤¸Æµ¿
  • sinus plate
    µ¿ÆÇ
  • sinus tympani
    °í½Çµ¿
  • sinus venosus
    Á¤¸Æµ¿
  • sphenoid sinus
    Á¢Çüµ¿
  • straight sinus
    Á÷Á¤¸Æµ¿
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CT calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ...
PTT partial thromboplastin time; particle transport time; posterior tibial tendon (transfer); prothrombi...
CSS Cancer Surveillance System; carotid sinus stimulation; carotid sinus syndrome; cavernous sinus syndr...
US/LS upper strength/lower strength [ratio]
MRT magnetic resonance tomography; maximum relaxation time; median range score; median reaction time; me...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CMPA cow milk protein allergy
CSNRT Corrected Sinus Node Recovery Time
SNRT SINUS NODE RECOVERY TIME
Day 0 day as
Day 1 day
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • milk allergy
    ¿ìÀ¯ ¾Ë·¹¸£±â
  • nasal allergy
    ºñ ¾Ë·¹¸£±â
  • parasitic allergy
    ±â»ýÃæ¼º ¾Ë·¹¸£±â
    ±â»ýÃæ °¨¿°À¸·Î ÀÎÇÑ ¾Ë·¹¸£±â.
  • penicillin allergy
    Æä´Ï½Ç¸° ¾Ë·¯Áö, Æä´Ï½Ç¸° ¾Ë·¹¸£±â
  • physical allergy
    ¹°¸®Àû ¾Ë·¹¸£±â
  • bending strength
    ±¼°î °­µµ, ±ÁÈû °­µµ
    º¸¿¡ »ý±â´Â ÃÖ´ë ±ÁÈû ÀÀ·Â.
  • compressive strength
    ¾ÐÃà °­µµ
    ¾ÐÃà ½ÃÇè¿¡ À־ Àç·á°¡ ÆÄ±«µÇ¾úÀ» ¶§ÀÇ ÇÏÁßÀ», ½ÃÇèÆíÀÇ ÃÖ¼Ò ´Ü¸éÀûÀ¸·Î ³ª´« °ÍÀ¸·Î, Àç·á°¡ ¾ÐÃà·ÂÀ» ¹ÞÀ» ¶§ ÀúÇ×ÇÏ´Â Èû.
  • edge strength
    ¿¬´Ü °­µµ
    ÆÄ¼â·Â¿¡ ´ëÇÑ ÃæÀü¹° º¯¿¬ÀÇ ÀúÇ×·Â.
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • fired strength
    ¼Ò¼º °­µµ
  • flexure strength
    ¿ä°î °­µµ
  • fracture strength
    ÆÄÀý °­µµ
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • margin strength
    º¯¿¬ °­µµ
    °­µµ¶õ ¾î¶² ¹°Ã¼¸¦ ÆÄ°ú½Ã۴µ¥ ÇÊ¿äÇÑ ÃÖ´ëÀÇ ÀÀ·ÂÀ¸·Î¼­ Àη¹ÀÌ ÁöÀ۽à marginal ridge ºÎÀ§¿¡ »ç¿ëµÇ´Â Àç·áÀÇ °­µµ¸¦ ¸»ÇÏ´Â °ÍÀ¸·Î º¯¿¬°­µµ°¡ Å« Àç·áÀÎ °æ¿ì¿¡´Â cavo-surface angleÀº µÐ°¢ÀÌ µÇ°í ±× ¹Ý´ëÀÎ °æ¿ì¿¡´Â Á÷°¢¿¡ °¡±õ°Ô Çü¼ºÇØÁØ´Ù.
  • marginal strength
    º¯¿¬ °­µµ, ¿¬´Ü °­µµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
strength-duration curve A graph relating the intensity of an electrical stimulus to the length of time it must flow to be effective.
See: chronaxie, rheobase.
(05 Mar 2000)
ionic strength Symbolised as g/2 or I and set equal to 0.5σmizi2, where mi equals the molar concentration and zi the charge of each ion present in solution; if molar concentrations (ci) are used instead of molality (and the solution is dilute), then I == 0.5(1/ρo)σcizi2 where ρo is the density of the solvent; a number of biochemically important events (e.g., protein solubility and rates of enzyme action) vary with the ionic strength of a solution.
(05 Mar 2000)
tensile strength The maximum stress a material subjected to a stretching load can withstand without tearing.
(12 Dec 1998)
yield strength The amount of stress at which a permanent (plastic) deformation in a component becomes measurable (usually taken as 0.2% permanent strain).
(05 Mar 2000)
ultimate strength The maximum stress achieved prior to failure of a component on a single application of the load.
(05 Mar 2000)
fatigue strength The stress level below which a particular component will survive an indefinite number of load cycles (typically about 50% of the ultimate strength of the component).
(05 Mar 2000)
allergy 1. <immunology> A state of hypersensitivity induced by exposure to a particular antigen (allergen) resulting in harmful immunologic reactions on subsequent exposures, the term is usually used to refer to hypersensitivity to an environmental antigen (atopic allergy or contact dermatitis) or to drug allergy.
The original meaning, now obsolete, included all states of altered immunologic reactivity, immunity as well as hypersensitivity. Gell and Coombs used the term allergic reaction to mean any harmful immunologic reaction causing tissue injury.
2. <study> The medical specialty dealing with diagnosis and treatment of allergic disorders.
(18 Nov 1997)
allergy and immunology A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder.
(12 Dec 1998)
allergy desensitization Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellowjackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and injections ( shots ) are usually required for 3-5 years.
(12 Dec 1998)
allergy shots See Allergy desensitization.
(12 Dec 1998)
allergy skin test Test done on the skin to identify the allergy substance (allergen) triggering the allergic reaction. A small amount of the suspected allergy substance is placed on the skin. The skin is then gently scratched through the small drop with a special sterile needle. If the skin reddens and, more importantly, swells, then allergy to that substance is probable.
(12 Dec 1998)
allergy testing <investigation> A common method of screening a patient for potential allergies. May be given as a patch or a skin test (injection).
(27 Sep 1997)
atopic allergy <immunology> An allergic reaction with strong family tendencies.
(09 Oct 1997)
bacterial allergy The concept that the atopic kind of type I allergic reactions may be caused by bacterial allergens, the delayed type of skin test, so-called because of its early association with bacterial antigens (e.g., the tuberculin test).
(05 Mar 2000)
physical allergy Excessive response to factors in the environment such as heat or cold.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • day to day
    ³ª³¯ÀÇ;±×³¯ ¹ú¾î ±×³¯ »ç´Â
  • all the time
    ±×µ¿¾È Á×,(¹Ì)¾ðÁ¦³ª
  • any time
    ¾ðÁ¦µçÁö
  • at a time
    Çѹø¿¡,µ¿½Ã¿¡
  • at any time
    ¾ðÁ¦¶óµµ
  • at that time
    ±×¶§,±×´ç½Ã
  • at the same time
    µ¿½Ã¿¡
  • at this time of ~
    ~ÀÇ À̸¾¶§
  • behind time
    ´ÊÀº
  • bide one's time
    ÁÁÀº½Ã±â¸¦ ±â´Ù¸®´Ù
  • by that time
    ±×¶§±îÁö
  • by the time
    ±×¶§Âë¿¡
  • by-time
    ¿©°¡
  • for the first time
    óÀ½À¸·Î
  • high time
    ²À ¾Ë¸ÂÀº ¶§
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á